NCT00335413View on ClinicalTrials.gov

Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

April 30, 2007

Conditions
Hypertension
Interventions
DRUG

Spironolactone

All Listed Sponsors
lead

Steno Diabetes Center Copenhagen

OTHER

NCT00335413 - Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone Therapy | Biotech Hunter | Biotech Hunter